๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of dexamethasone and cycloheximide on the expression of amplified EGF-receptor gene in human A431 carcinoma cell line

โœ Scribed by Mohan L. Gope; Rajalakshmi Gope; Tanya Zarucki


Publisher
Springer
Year
1991
Tongue
English
Weight
474 KB
Volume
103
Category
Article
ISSN
0300-8177

No coin nor oath required. For personal study only.

โœฆ Synopsis


Human A431 carcinoma cell line is known to have 30 fold amplified epidermal growth factor receptor (EGF-R) gene. We have studied the effect of steroid hormone dexamethasone (DEX) and protein synthesis inhibitor cycloheximide (CHX) on the expression of EGF-R gene in this cell line. DEX treatment and protein synthesis inhibition by CHX treatment cause a rapid 3 to 4 fold increase in the level of EGF-R mRNA and combined treatment of the above two agents have less than additive effect. It appears that mRNA for EGF-R accumulate within the cell during protein synthesis inhibition and upon removal of CHX, gets translated into EGF-R specific protein as judged by immuno-dot assay. We did not observe the phenomenon of 'super induction' nor much of an additive effect under condition of combined DEX and CHX treatment.


๐Ÿ“œ SIMILAR VOLUMES


EGF stimulates anchorage-independent gro
โœ Jiro Ishikawa; Sakan Maeda; Taketoshi Sugiyama; Ryuichiro Nishimura; Akira Mizog ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 695 KB

Southern blot analysis of 6 human bladder carcinoma cell lines revealed amplification of the epidermal growth factor receptor (EGFR) gene in the KUI cell line. The amplification of the gene was about 4-fold as compared with that of human placental DNA. Several restriction endonuclease digestions rev

Effects of tyrosine kinase inhibitor, er
โœ Naoki Takekura; Wataru Yasui; Eikai Kyo; Kazuhiro Yoshida; Takashi Kameda; Yasuh ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 571 KB

The effect of tyrosine kinase inhibitor, erbstatin, on cell growth and mRNA expression of growth-factor/receptor system was examined in 6 human gastric-carcinoma cell lines. Erbstatin inhibited both EGF-induced and serum-stimulated cell growth of all 6 cell lines (TMK-I, MKN-I, -7, -28, -45, -74) in